We are live on ! Find out more
CBIO

Crescent Biopharma
CBIO

41 hedge funds and large institutions have $7.56M invested in Crescent Biopharma in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more capital invested

Capital invested by funds: $3M → $7.56M (+$4.55M)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

14% more funds holding

Funds holding: 36 → 41 (+5)

0.19% more ownership

Funds ownership: 0.28% → 0.47% (+0.19%)

Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
6
Reduced
4
Closed
11
Calls
$26K
Puts
–
Net Calls
+$26K
Net Calls Change
+$26K

Top Buyers

1
LGM
Logos Global Management
California
+$1.47M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.39M
3
VA
VR Adviser
New York
+$818K
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$385K
5
JFG
Jefferies Financial Group
New York
+$116K

Top Sellers

1
SL
Siren LLC
Connecticut
-$332K
2
Renaissance Technologies
Renaissance Technologies
New York
-$202K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$97.1K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$42.1K
5
HWA
HCR Wealth Advisors
California
-$16.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
JF
51
Jump Financial
Illinois
– -$1.95K -115 Closed
1 2
3